Special Issue on "Hepatitis C in the Middle East and North Africa"

The Middle East and North Africa (MENA) region has the highest prevalence and burden of hepatitis C worldwide. While there is great ambition toward the elimination of hepatitis C worldwide, most of MENA countries are far from achieving the hepatitis C elimination goals. One of the obstacles is the lack of reliable scientific evidences on epidemiologic, virologic and clinical aspects of hepatitis C needed for policy making and advocacy of health interventions.
This Special Issue of Hepatitis Monthly invites all researchers in MENA region to submit their studies on hepatitis C to help the regional elimination of hepatitis C. The editorial board would offer 40% discount on all manuscripts accepted for this special issue. The submission for this special issue is open at https://hepatmon.brieflands.com/en/user/login

Special Issue Theme:

• Elimination of hepatitis C in MENA

Topics of particular interest:

• Epidemiology of hepatitis C in special populations (e.g. PWID, FSW, thalassemia, etc.)
• Molecular epidemiology of hepatitis C
• Efficacy and safety of hepatitis C direct-acting antivirals
• Hepatitis C resistance to direct-acting antivirals
• Hepatitis C model of care in special populations
• Micro-elimination and elimination of hepatitis C
• Management of hepatic and extra-hepatic complications of hepatitis C
• Burden of hepatitis C advanced liver diseases

Article types:

• Original articles
• Brief reports
• Review articles
• Letter to editors

Editor-in-chief:

• Seyed Moayed Alavian, Middle East Liver Diseases Center, Iran; Email: alavian@thc.ir

Guest associate editors:

• Wasim Jafri, Aga Khan University, Pakistan; Email: wasim.jafri@aku.edu
• Imam Waked, National Liver Institute, Menoufiya University, Egypt; Email: iwaked@liver-eg.org
• Heidar Sharafi, Middle East Liver Diseases Center, Iran; Email: h.sharafi@meldcenter.com

Submission deadline:

• 30 September 2022

Published Articles:

• This list will be updated regularly.